NCT05896137 - CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions

Primary Sclerosing Cholangitis

Interventions

DRUG

CS0159

Oral QD

Trial Locations (12)

RECRUITING

Beijing Friendship Hospital, Captail Medcial University, Beijing

RECRUITING

Beijing YouAn Hostital, Captial Medical University, Beijing

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

RECRUITING

Shaoyifu Hospital of Zhejiang University Medical, Hangzhou

RECRUITING

The Seconed Xiangya Hospital of Central South University, Changsha

RECRUITING

Wuhan Union Hospital of China, Wuhan

RECRUITING

The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei

RECRUITING

The First Bethune Hospital of Jilin University, Changchun

RECRUITING

Qilu Hospital of Shandong University, Jinan

NOT_YET_RECRUITING

The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou